Literature DB >> 9060641

Characterization of synthetic foot-and-mouth disease virus provirions separates acid-mediated disassembly from infectivity.

T Knipe1, E Rieder, B Baxt, G Ward, P W Mason.   

Abstract

One of the final steps in the maturation of foot-and-mouth disease virus (FMDV) is cleavage of the VP0 protein to produce VP4 and VP2. The mechanism of this cleavage is unknown, but it is thought to function in stabilizing the virus particle and priming it for infecting cells. To investigate the cleavage process and to understand its role in virion maturation, we engineered synthetic FMDV RNAs with mutations at Ala-85 (A85) and Asp-86 (D86) of VP0, which border the cleavage site. BHK cells transfected with synthetic RNAs containing substitutions at position 85 (A85N or A85H) or at position 86 (D86N) yielded particles indistinguishable from wild-type (WT) virus in sedimentation and electrophoretic profiles. Viruses derived from these transfected cells were infectious and maintained their mutant sequences upon passage. However, BHK cells transfected with synthetic RNAs encoding Phe and Lys at these positions (A85F/D86K) or a Cys at position 86 (D86C) produced noninfectious provirions with uncleaved VP0 molecules. Despite their lack of infectivity, the A85F/D86K provirions displayed cell binding and acid sensitivity similar to those of WT virus. However, acid breakdown products of the A85F/D86K provirions differed in hydrophobicity from the comparable WT virion products, which lack VP4. Taken together, these studies are consistent with a role for soluble VP4 molecules in release of the viral genome from the endosomal compartment of susceptible cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9060641      PMCID: PMC191410     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Capsid intermediates assembled in a foot-and-mouth disease virus genome RNA-programmed cell-free translation system and in infected cells.

Authors:  M J Grubman; D O Morgan; J Kendall; B Baxt
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

2.  Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell-free system from clone-derived transcripts.

Authors:  V N Vakharia; M A Devaney; D M Moore; J J Dunn; M J Grubman
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

3.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

4.  Implications of the picornavirus capsid structure for polyprotein processing.

Authors:  E Arnold; M Luo; G Vriend; M G Rossmann; A C Palmenberg; G D Parks; M J Nicklin; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

5.  Phase separation of integral membrane proteins in Triton X-114 solution.

Authors:  C Bordier
Journal:  J Biol Chem       Date:  1981-02-25       Impact factor: 5.157

6.  Effect of lysosomotropic compounds on early events in foot-and-mouth disease virus replication.

Authors:  B Baxt
Journal:  Virus Res       Date:  1987-05       Impact factor: 3.303

7.  A second protease of foot-and-mouth disease virus.

Authors:  K Strebel; E Beck
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

8.  Processing and assembly of foot-and-mouth disease virus proteins using subgenomic RNA.

Authors:  B E Clarke; D V Sangar
Journal:  J Gen Virol       Date:  1988-09       Impact factor: 3.891

9.  Effect of lysosomotropic agents on the foot-and-mouth disease virus replication.

Authors:  E C Carrillo; C Giachetti; R H Campos
Journal:  Virology       Date:  1984-06       Impact factor: 3.616

10.  Early steps in FMDV replication: further analysis on the effects of chloroquine.

Authors:  E C Carrillo; C Giachetti; R Campos
Journal:  Virology       Date:  1985-11       Impact factor: 3.616

View more
  24 in total

Review 1.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins.

Authors:  J Chinsangaram; C Beard; P W Mason; M K Zellner; G Ward; M J Grubman
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus.

Authors:  S Curry; E Fry; W Blakemore; R Abu-Ghazaleh; T Jackson; A King; S Lea; J Newman; D Stuart
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Analysis of foot-and-mouth disease virus internalization events in cultured cells.

Authors:  Vivian O'Donnell; Michael LaRocco; Hernando Duque; Barry Baxt
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid resistance.

Authors:  Miguel A Martín-Acebes; Angela Vázquez-Calvo; Verónica Rincón; Mauricio G Mateu; Francisco Sobrino
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

6.  Positively charged residues at the five-fold symmetry axis of cell culture-adapted foot-and-mouth disease virus permit novel receptor interactions.

Authors:  Stephen Berryman; Stuart Clark; Naresh K Kakker; Rhiannon Silk; Julian Seago; Jemma Wadsworth; Kyle Chamberlain; Nick J Knowles; Terry Jackson
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

7.  The rescue and selection of thermally stable type O vaccine candidate strains of foot-and-mouth disease virus.

Authors:  Ya Gao; Pinghua Li; Xueqing Ma; Xingwen Bai; Pu Sun; Ping Du; Hong Yuan; Yimei Cao; Kun Li; Yuanfang Fu; Jing Zhang; Huifang Bao; Yingli Chen; Zhiyong Li; Zengjun Lu; Zaixin Liu; Dong Li
Journal:  Arch Virol       Date:  2021-05-18       Impact factor: 2.574

8.  A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid lability and confer resistance to acid-dependent uncoating inhibition.

Authors:  Miguel A Martín-Acebes; Verónica Rincón; Rosario Armas-Portela; Mauricio G Mateu; Francisco Sobrino
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

9.  Foot-and-mouth disease virus assembly: processing of recombinant capsid precursor by exogenous protease induces self-assembly of pentamers in vitro in a myristoylation-dependent manner.

Authors:  Stewart Goodwin; Tobias J Tuthill; Armando Arias; Richard A Killington; David J Rowlands
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

10.  Caveolar endocytosis is required for human PSGL-1-mediated enterovirus 71 infection.

Authors:  Hsiang-Yin Lin; Ya-Ting Yang; Shu-Ling Yu; Kuang-Nan Hsiao; Chia-Chyi Liu; Charles Sia; Yen-Hung Chow
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.